Fredrik Dalborg

Fredrik Dalborg is an accomplished executive with extensive leadership experience in the life sciences and medical technology sectors. Currently serving as CEO of AddLife AB, a European provider in life science, Fredrik's prior roles include Managing Director North America at XVIVO, CEO and Group President at Etac Group, and CEO of Boule Diagnostics. Fredrik's career highlights also include significant positions at Terumo BCT, Gambro BCT, and Gambro AB, where responsibilities ranged from global business development to investor relations. Fredrik holds a Master’s Degree in Economics and Business Administration from the Stockholm School of Economics and has pursued executive education at prestigious institutions, including Harvard Business School and MIT Sloan School of Management.